Patents by Inventor Kevin Coleman
Kevin Coleman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11922733Abstract: A method of enrolling a user at a biometric lockset is described. The method includes receiving user access information from a mobile device of an administrative user of the biometric lockset. The user access information indicates to the biometric lockset to enter an enrollment mode in which a user identity is associated with fingerprint data in a user entry within a memory of the biometric lockset. A plurality of different light codes are displayed on the lockset, each one of the plurality of light codes representative of a different state of fingerprint data capture. A message is transmitted to the mobile device, and corresponds to the light code displayed at the lockset. The completed fingerprint data is stored in association with the user identity of the user in the user entry.Type: GrantFiled: November 11, 2022Date of Patent: March 5, 2024Assignee: ASSA ABLOY Americas Residential Inc.Inventors: Wei Hsu, Kevin Pasma, Zachary Keoki Hong, Jason Tu, Donnie Viajar, Ali Atash, Kevin Coleman
-
Publication number: 20230144744Abstract: A method of enrolling a user at a biometric lockset is described. The method includes receiving user access information from a mobile device of an administrative user of the biometric lockset. The user access information indicates to the biometric lockset to enter an enrollment mode in which a user identity is associated with fingerprint data in a user entry within a memory of the biometric lockset. A plurality of different light codes are displayed on the lockset, each one of the plurality of light codes representative of a different state of fingerprint data capture. A message is transmitted to the mobile device, and corresponds to the light code displayed at the lockset. The completed fingerprint data is stored in association with the user identity of the user in the user entry.Type: ApplicationFiled: November 11, 2022Publication date: May 11, 2023Inventors: Wei Hsu, Kevin Pasma, Zachary Keoki Hong, Jason Tu, Donnie Viajar, Ali Atash, Kevin Coleman
-
Patent number: 11501579Abstract: A method of enrolling a user at a biometric lockset is described. The method includes receiving user access information from a mobile device of an administrative user of the biometric lockset. The user access information indicates to the biometric lockset to enter an enrollment mode in which a user identity is associated with fingerprint data in a user entry within a memory of the biometric lockset. A plurality of different light codes are displayed on the lockset, each one of the plurality of light codes representative of a different state of fingerprint data capture. A message is transmitted to the mobile device, and corresponds to the light code displayed at the lockset. The completed fingerprint data is stored in association with the user identity of the user in the user entry.Type: GrantFiled: November 25, 2020Date of Patent: November 15, 2022Assignee: Spectrum Brands, Inc.Inventors: Wei Hsu, Kevin Pasma, Zachary Keoki Hong, Jason Tu, Donnie Viajar, Ali Atash, Kevin Coleman
-
Publication number: 20210158067Abstract: A method of enrolling a user at a biometric lockset is described. The method includes receiving user access information from a mobile device of an administrative user of the biometric lockset. The user access information indicates to the biometric lockset to enter an enrollment mode in which a user identity is associated with fingerprint data in a user entry within a memory of the biometric lockset. A plurality of different light codes are displayed on the lockset, each one of the plurality of light codes representative of a different state of fingerprint data capture. A message is transmitted to the mobile device, and corresponds to the light code displayed at the lockset. The completed fingerprint data is stored in association with the user identity of the user in the user entry.Type: ApplicationFiled: November 25, 2020Publication date: May 27, 2021Inventors: Wei Hsu, Kevin Pasma, Zachary Keoki Hong, Jason Tu, Donnie Viajar, Ali Atash, Kevin Coleman
-
Patent number: 8562985Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies.Type: GrantFiled: April 24, 2012Date of Patent: October 22, 2013Assignees: Amgen Fremont Inc., Pfizer Inc.Inventors: Neil R. Michaud, Shama Kajiji, Gary Borzillo, Vahe Bedian, Kevin Coleman, Larry L. Green, Xiao-Chi Jia
-
Publication number: 20120321614Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies.Type: ApplicationFiled: April 24, 2012Publication date: December 20, 2012Applicants: Pfizer, Inc., Amgen Fremont Inc.Inventors: Neil R. Michaud, Shama Kajiji, Gary Borzillo, Vahe Bedian, Kevin Coleman, Larry L. Green, Xiao-Chi Jia
-
Patent number: 8163280Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies.Type: GrantFiled: January 26, 2009Date of Patent: April 24, 2012Assignees: Amgen Fremont Inc., Pfizer Inc.Inventors: Neil R. Michaud, Shama Kajiji, Gary Borzillo, Vahe Bedian, Kevin Coleman, Larry L. Green, Xiao-Chi Jia
-
Publication number: 20100040629Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies.Type: ApplicationFiled: January 26, 2009Publication date: February 18, 2010Applicants: Abgenix, Inc., Pfizer, Inc.Inventors: Neil R. Michaud, Shama Kajiji, Gary Borzillo, Vahe Bedian, Kevin Coleman, Larry L. Green, Xiao-Chi Jia
-
Patent number: 7498420Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies.Type: GrantFiled: August 3, 2004Date of Patent: March 3, 2009Assignees: Amgen Fremont Inc., Pfizer Inc,Inventors: Neil R. Michaud, Shama Kajiji, Gary Borzillo, Vahe Bedian, Kevin Coleman, Larry L. Green, Xiao-Chi Jia
-
Publication number: 20050054019Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to c-Met, preferably human c-Met, and that function to inhibit c-Met. The invention also relates to human anti-c-Met antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-c-Met antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-c-Met antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-c-Met antibodies.Type: ApplicationFiled: August 3, 2004Publication date: March 10, 2005Inventors: Neil Michaud, Shama Kajiji, Gary Borzillo, Vahe Bedian, Kevin Coleman, Larry Green, Xiao-Chi Jia
-
Patent number: 5620099Abstract: The invention relates to a combined portable scoring system and storage/carrier unit. There is disclosed a portable storage/carrier unit which is intended to be used for storing and carrying sporting equipment of any type when used or not used for scoring a game. Upon arrival at a game site, the equipment and first-aid supplies are removed as needed from the storage/carrier unit, closed and placed in an upright position. The storage/carrier unit includes a plurality of pockets formed in the outer planar surface of at least one side of the unit by a plurality of continuous tracks and accommodates scoring number packets, home team and guest team names as well as a sponsor's name. A centrally located rotary pointer dial is provided to indicate the inning or quarter of play. An out indicator is provided as well.Type: GrantFiled: November 28, 1994Date of Patent: April 15, 1997Inventors: Earl H. Bickett, Kevin Coleman, Michael Yurkovic